共 19 条
[3]
Craddock C, 2000, BRIT J HAEMATOL, V111, P797
[4]
Flowers CR, 2000, BLOOD, V96, p521A
[7]
Giralt S, 1999, Cancer Treat Res, V101, P97
[8]
The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications
[J].
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH,
1999, 8 (04)
:387-391